Stocks and Investing Stocks and Investing
Fri, March 5, 2021
[ 12:00 AM ] - WOPRAI
Kimberly Greenberger Maintained (BURL) at Buy with Increased Target to $290 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Mark Altschwager Maintained (BURL) at Buy with Increased Target to $325 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Paul Trussell Maintained (BURL) at Strong Buy with Increased Target to $320 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Kate Fitzsimons Maintained (BURL) at Buy with Increased Target to $320 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
John Kernan Maintained (BURL) at Buy with Increased Target to $310 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Janine Stichter Maintained (BURL) at Strong Buy with Increased Target to $355 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Joshua Tilton Upgraded (ZS) to Strong Buy and Increased Target to $235 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Patrick Scholes Maintained (VAC) at Strong Buy with Increased Target to $184 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Darren Aftahi Maintained (VERI) at Strong Buy with Increased Target to $50 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Nat Schindler Upgraded (CDLX) to Hold and Held Target at $128 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Alexander Goldfarb Maintained (SPG) at Buy with Increased Target to $130 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Steve Dyer Downgraded (SWBI) to Hold and Held Target at $17 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Toshiya Hari Downgraded (SWKS) to Hold and Held Target at $135 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Geoffrey Porges Maintained (AMGN) at Hold with Increased Target to $260 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Increased Target to $279 on, Mar 5th, 2021
[ 12:00 AM ] - WOPRAI
Carter Gould Maintained (AMGN) at Hold with Decreased Target to $230 on, Mar 5th, 2021
Thu, March 4, 2021
[ 12:00 AM ] - WOPRAI
Sarah Akers Downgraded (SR) to Hold and Decreased Target to $69 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Craig Kucera Upgraded (BFS) to Strong Buy and Increased Target to $50 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Upgraded (BEP) to Hold and Decreased Target to $42 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Upgraded (BE) to Buy and Held Target at $33 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Richard Repetto Upgraded (CBOE) to Buy and Increased Target to $108 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Shyam Patil Initiated (BMBL) at Buy and Held Target at $78 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Andrew DeGasperi Initiated (BL) at Strong Buy and Held Target at $150 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Ken Hoexter Upgraded (SNDR) to Strong Buy and Increased Target to $28 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Patrick Colville Upgraded (SNOW) to Strong Buy and Increased Target to $300 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (SNOW) at Hold with Increased Target to $270 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (SNOW) at Hold with Decreased Target to $295 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Raimo Lenschow Maintained (SNOW) at Hold with Decreased Target to $270 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Brad Zelnick Maintained (SNOW) at Hold with Decreased Target to $275 on, Mar 4th, 2021
[ 12:00 AM ] - WOPRAI
Nathan Weinstein Initiated (CDTX) at Strong Buy and Held Target at $180 on, Mar 4th, 2021

Nathan Weinstein Initiated (CDTX) at Strong Buy and Held Target at $180 on, Mar 4th, 2021


Published on 2024-10-27 15:51:13 - WOPRAI, Nathan Weinstein
  Print publication without navigation


Nathan Weinstein of Aegis Capital, Initiated "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $180 on, Mar 4th, 2021.

Nathan, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources